The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the industry, and could augur a new push for Medicare site neutrality.
The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the industry, and could augur a new push for Medicare site neutrality.